{
    "Trade/Device Name(s)": [
        "QuickVue Influenza A + B test"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K131619",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "June 28, 2013",
    "Summary Letter Received Date": "June 03, 2013",
    "Submission Date": "May 31, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "immunology"
    ],
    "Analyte(s)": [
        "Influenza type A antigen",
        "Influenza type B antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Nasal aspirate",
        "Nasal wash"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunological assay",
        "Lateral flow"
    ],
    "Methodologies": [
        "Antigen detection",
        "Visual detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Strip test",
        "Reagent",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for QuickVue Influenza A + B test, a rapid immunological lateral flow assay for detection of influenza A and B antigens in respiratory specimens",
    "Indications for Use Summary": "Aids in rapid differential diagnosis of acute influenza type A and B infections by qualitatively detecting their antigens in nasal and nasopharyngeal swab, nasal aspirate, and nasal wash specimens; for professional and laboratory use",
    "fda_folder": "Microbiology"
}